This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
28,313 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Insider buying can hint at confidence from leadership, but it isn’t a crystal ball. This guide explains how to interp...
Amazon employees are reportedly gaming internal AI token counts to climb leaderboards, prompting expert warnings abou...
Intel faces a pivotal moment as Q1 losses mount and cash burn deepens. Analysts and investors debate buy, hold sell i...
Tuesday’s market action centers on fresh analyst calls for Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Ve...
A single conference-call moment changed the mood around Eli Lilly. By unpacking eight key themes from the CEO, invest...
Waabi’s Raquel Urtasun argues that Gen Z’s curiosity and adaptability give them a competitive edge as AI reshapes tru...
Duquesne Family Office revealed positions in three AI infrastructure semiconductor firms, signaling a thematic bet on...
NVIDIA commands the AI software and platform stack, while Micron powers the memory that feeds it. Investors bet on wh...
As Amazon navigates a pivot from retail growth to AI infrastructure and cloud services, investors weigh margin shifts...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
If you’re searching for a medical-device stock you can own for decades, Medtronic stands out. This article breaks dow...